Acta Medica Scandinavica

Cover image for Acta Medica Scandinavica

January/December 1966

Volume 180, Issue S469

Pages 5–42

Currently known as: Journal of Internal Medicine

  1. Introduction and purpose of the investigation

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. I. Introduction and purpose of the investigation (page 5)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05126.x

  2. Clinical material

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. II. Clinical material (pages 6–7)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05127.x

  3. Methods

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. III. Methods (pages 8–12)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05128.x

  4. Treatment and control

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. IV. Treatment and control (pages 13–16)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05129.x

  5. Bodyweight and other anthropometric data

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. V. Bodyweight and other anthropometric data (pages 17–18)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05130.x

  6. Original Article

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
  7. The development of diabetic retinopathy

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. VII. The development of diabetic retinopathy (pages 22–29)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05132.x

  8. Various clinical observations in diabetics

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. VII. Various clinical observations in diabetics (pages 30–36)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05133.x

  9. Glutamic - Pyruvic - Transaminase (Gpt)

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. IX. Glutamic - Pyruvic - Transaminase (Gpt) (pages 37–38)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05134.x

  10. Discussion

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. X. Discussion (pages 39–40)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05135.x

  11. Summary

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. XI. Summary (page 41)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05136.x

  12. References

    1. Top of page
    2. Introduction and purpose of the investigation
    3. Clinical material
    4. Methods
    5. Treatment and control
    6. Bodyweight and other anthropometric data
    7. Original Article
    8. The development of diabetic retinopathy
    9. Various clinical observations in diabetics
    10. Glutamic - Pyruvic - Transaminase (Gpt)
    11. Discussion
    12. Summary
    13. References
    1. References (page 42)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1966.tb05137.x

SEARCH

SEARCH BY CITATION